PHG

MKT CAP:$26B

Koninklijke Philips N.V.

Market Cap

$26B

Healthcare·Medical - Devices·🇳🇱 Netherlands·NYSE

Healthcare·Medical - Devices·🇳🇱·NYSE

Stock Price

$27.55+$0.48 (+1.79%)

Apr 23, 2026

Company Details

Koninklijke Philips N.V. operates as a health technology company in North America and internationally. It operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. The company pro...

CEO

Roy W. O. Jakobs

IPO Date

Mar 17, 1980

Website

www.philips.com

Key Metrics TTM

Revenue

$22.0B

+9.1% YoY

Net Income

$497M

EPS (Diluted)

$0.51

Free Cash Flow

$1.8B

Revenue / Share

$22.78

Gross Margin

43.4%

Operating Margin

7.5%

Net Margin

2.3%

FCF Margin

8.3%

P/S

1.2x

P/E

52.9x

Earnings Reports

Q1 2026

May 5, 2026

PENDING

FY 2025

Feb 19, 2026

$20.9BEPS $1.09

Q4 2025

Feb 19, 2026

$6.0B+1.1%EPS $0.48

Q3 2025

Nov 4, 2025

$5.0B-1.7%EPS $0.22

Q4 2024

Feb 21, 2025

$5.9BEPS -$0.42

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q1 21	$4.5B	$1.7B	-$61M
Q2 21	$4.9B	$2.1B	$99M
Q3 21	$4.9B	$2.3B	$419M
Q4 21	$5.8B	$2.3B	$189M
Q1 22	$4.6B	$1.8B	-$212M
Q2 22	$4.9B	$2.0B	$13M
Q3 22	$5.0B	$2.0B	-$1.8B
Q4 22	$6.3B	$2.6B	$200M
Q1 23	$4.9B	$2.1B	-$682M
Q2 23	$5.2B	$2.3B	$258M
Q3 23	$5.2B	$2.3B	$262M
Q1 24	$4.8B	$2.1B	-$963M
Q3 24	$5.1B	$2.3B	$394M
Q4 24	$5.9B	$2.3B	$233M
Q3 25	$5.0B	$2.2B	$386M
Q4 25	$6.0B	$2.7B	$631M

Valuation

Quarter	P/S	P/E
Q1 21	2.3x	35.8x
Q2 21	2.0x	33.3x
Q3 21	1.9x	9.1x
Q4 21	1.5x	7.9x
Q1 22	1.2x	6.7x
Q2 22	0.9x	5.5x
Q3 22	0.7x	—
Q4 22	0.7x	—
Q1 23	0.8x	—
Q2 23	0.9x	—
Q3 23	0.9x	—
Q1 24	0.9x	—
Q3 24	1.5x	—
Q4 24	1.1x	—
Q3 25	1.2x	—
Q4 25	1.2x	53.1x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 21	$0	$0
Q2 21	$0	$0
Q3 21	$0	$0
Q4 21	$0	$0
Q1 22	$0	$0
Q2 22	$0	$0
Q3 22	$0	$0
Q4 22	$122M	$122M
Q1 23	$0	$0
Q2 23	$0	$0
Q3 23	$0	$0
Q1 24	-$200M	-$399M
Q3 24	$0	$0
Q4 24	$0	$0
Q3 25	$382M	$303M
Q4 25	$1.6B	$1.5B

Capital Expenditures

Quarter	CapEx
Q1 21	$0
Q2 21	$0
Q3 21	$0
Q4 21	$0
Q1 22	$0
Q2 22	$0
Q3 22	$0
Q4 22	$0
Q1 23	$0
Q2 23	$0
Q3 23	$0
Q1 24	$199M
Q3 24	$0
Q4 24	$0
Q3 25	$80M
Q4 25	$97M

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 21	-8.0%	-5.8%
Q2 21	+6.4%	+10.0%
Q3 21	-16.5%	-15.7%
Q4 21	-17.6%	-8.2%
Q1 22	+2.4%	+5.7%
Q2 22	-1.3%	+0.5%
Q3 22	+3.7%	+53.7%
Q4 22	+9.7%	+9.8%
Q1 23	+6.4%	+15.9%
Q2 23	+7.0%	+2.0%
Q3 23	+3.7%	-27.3%
Q1 24	-23.7%	-5.5%
Q3 24	+5.0%	-14.9%
Q4 24	+12.8%	+14.0%
Q3 25	-3.8%	-6.5%
Q4 25	+23.2%	-8.2%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 21	$0	0.0%
Q2 21	$0	0.0%
Q3 21	$0	0.0%
Q4 21	$134M	2.3%
Q1 22	$0	0.0%
Q2 22	$0	0.0%
Q3 22	$0	0.0%
Q4 22	$122M	1.9%
Q1 23	$0	0.0%
Q2 23	$0	0.0%
Q3 23	$0	0.0%
Q1 24	$29M	0.6%
Q3 24	$0	0.0%
Q4 24	$122M	2.1%
Q3 25	$37M	0.7%
Q4 25	$35M	0.6%

OpEx Breakdown

Quarter	R&D	G&A	S&M
Q1 21	$496M	$202M	$1.2B
Q2 21	$550M	$161M	$1.2B
Q3 21	$511M	$192M	$1.2B
Q4 21	$756M	$145M	$1.2B
Q1 22	$579M	$181M	$1.2B
Q2 22	$568M	$171M	$1.3B
Q3 22	$716M	$205M	$1.4B
Q4 22	$588M	$228M	$1.5B
Q1 23	$617M	$185M	$1.3B
Q2 23	$547M	$184M	$1.3B
Q3 23	$520M	$175M	$1.3B
Q1 24	$490M	$159M	$1.3B
Q3 24	$506M	$177M	$1.3B
Q4 24	$552M	$160M	$1.4B
Q3 25	$484M	$180M	$1.2B
Q4 25	$499M	$185M	$1.3B

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$0	$5.4B	$5.4B
Q2 22	$1.5B	$9M	$1.5B
Q3 22	$0	$3.0B	$3.0B
Q4 22	$1.4B	$13M	$1.4B
Q1 23	$0	$0	$0
Q2 23	$1.1B	$9M	$1.1B
Q3 23	$0	$2.3B	$2.3B
Q4 23	$2.2B	$4M	$2.2B
Q1 24	$0	$4.4B	$4.4B
Q2 24	$2.1B	$7M	$2.1B
Q3 24	$0	$0	$0
Q4 24	$2.8B	$2M	$2.8B
Q1 25	$1.4B	$2M	$1.4B
Q2 25	$2.1B	$2M	$2.1B
Q3 25	$2.2B	$0	$2.2B
Q4 25	$3.3B	$0	$3.3B

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q1 21	955M	-0.2%	-0.4%
Q2 21	956M	+0.2%	+0.1%
Q3 21	958M	+0.2%	+0.2%
Q4 21	934M	-2.5%	-2.3%
Q1 22	917M	-1.8%	-3.9%
Q2 22	884M	-3.6%	-7.5%
Q3 22	918M	+3.9%	-4.1%
Q4 22	917M	-0.1%	-1.9%
Q1 23	882M	-3.9%	-3.9%
Q2 23	947M	+7.4%	+7.1%
Q3 23	948M	+0.1%	+3.2%
Q1 24	937M	-1.1%	+2.2%
Q3 24	913M	-2.5%	+3.6%
Q4 24	929M	+1.8%	-1.8%
Q3 25	964M	+3.7%	+1.7%
Q4 25	966M	+0.2%	+3.1%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q1 21	$54.8K	82K
Q2 21	$60.6K	82K
Q3 21	$59.6K	82K
Q4 21	$73.9K	78K
Q1 22	$58.6K	78K
Q2 22	$62.5K	78K
Q3 22	$64.4K	78K
Q4 22	$317.0K	20K
Q1 23	$243.6K	20K
Q2 23	$261.3K	20K
Q3 23	$261.4K	20K
Q1 24	$170.4K	28K
Q3 24	$180.2K	28K
Q4 24	$240.3K	25K
Q3 25	$204.9K	25K
Q4 25	$242.8K	25K

Revenue / Employee